tiprankstipranks
Trending News
More News >
WuXi AppTec Co., Ltd. Class H (HK:2359)
:2359
Hong Kong Market

Compare WuXi AppTec Co., Ltd. Class H (2359) vs. Competitors

Compare
33 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
WuXi AppTec Co., Ltd. Class H
HK$98.70
HK$323.45B
19.96
111.56%
9 Buy
1 Hold
0 Sell
Strong Buy
Wuxi Biologics (Cayman)
HK$37.06
$153.19B
33.25
119.03%
2 Buy
1 Hold
0 Sell
Moderate Buy
Hangzhou Tigermed Consulting Co., Ltd. Class H
HK$50.95
€52.82B
65.18
77.22%
4 Buy
0 Hold
1 Sell
Moderate Buy
Pharmaron Beijing Co., Ltd. Class H
HK$24.14
HK$58.34B
25.02
77.76%
5 Buy
0 Hold
0 Sell
Strong Buy
Hansoh Pharmaceutical Group Company Limited
HK$41.60
HK$251.89B
47.92
152.43%
5 Buy
1 Hold
0 Sell
Strong Buy
WuXi XDC Cayman, Inc.
HK$70.90
HK$89.00B
59.45
127.61%
4 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:2359
WuXi AppTec Co., Ltd. Class H
111.60
60.93
120.25%
HK:2269
Wuxi Biologics (Cayman)
37.06
20.16
119.29%
HK:3347
Hangzhou Tigermed Consulting Co., Ltd. Class H
50.95
22.78
80.85%
HK:3759
Pharmaron Beijing Co., Ltd. Class H
23.18
10.77
86.71%
HK:3692
Hansoh Pharmaceutical Group Company Limited
41.60
25.52
158.71%
HK:2268
WuXi XDC Cayman, Inc.
70.90
42.00
145.33%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts